Does LEUPROLIDE Cause Lymphadenopathy? 177 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Lymphadenopathy have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.3% of all adverse event reports for LEUPROLIDE.
177
Reports of Lymphadenopathy with LEUPROLIDE
0.3%
of all LEUPROLIDE reports
20
Deaths
43
Hospitalizations
How Dangerous Is Lymphadenopathy From LEUPROLIDE?
Of the 177 reports, 20 (11.3%) resulted in death, 43 (24.3%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
Yes, Lymphadenopathy is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which LEUPROLIDE Alternatives Have Lower Lymphadenopathy Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM